Navitas Life Sciences

Nuclear Point for Macro-Sized Clinical Research and Development

With the Indian clinical trials market expected to grow at a CAGR of 8.7% between 2017 and 2025, we are riding the digitalization wave.

Our Managing Director, Srinivasan H R, talks to CEO Insights magazine, featuring in their ‘Top 10 Clinical Trials Service Providers 2020’ to discuss how our technology enablers empower seamless execution and quick results for our clients.

Please complete the form to download and read the article to learn how we offer a perfect blend of clinical capabilities and technology expertise to run virtual trials.

Interview published in CEO Insights Magazine | Volume 03 – Issue 10 – 3 December 04, 2020

ceoinsightsindia

Please complete form to download PDF
First Name
✽
Last Name
✽
Business Email
✽
Company
✽
Job Title
✽
Country
✽
By submitting this form, I agree to receive email communications from Navitas Life Sciences. Privacy Policy | EU-US & Swiss-US Privacy Shield Policy

© 2021 Navitas Life Sciences | Privacy Policy